Literature DB >> 11854327

Interactions between endothelial nitric oxide synthase and sex hormones in vascular protection in mice.

Jeffrey B Hodgin1, Joshua W Knowles, Hyung-Suk Kim, Oliver Smithies, Nobuyo Maeda.   

Abstract

The vasculoprotective effects of sex hormones, particularly estrogens, have been attributed to their ability to increase the bioavailability of nitric oxide through activation of endothelial nitric oxide synthase (eNOS). To dissect the relative contribution in vivo of eNOS, sex hormones, and their interaction in two complex vascular phenotypes, hypertension and atherosclerosis, we used mice doubly deficient in eNOS and apoE (nnee) or lacking only apoE (NNee). Females and males were gonadectomized at 1 month of age and implanted either with control pellets or pellets releasing 17beta-estradiol (E2). Hormonally intact nnee mice have elevated blood pressure (BP) and increased atherosclerosis compared with NNee mice, but on removal of gonads, BP and atherosclerosis decreased significantly in nnee mice but not in NNee mice. Three months of treatment with exogenous E2 dramatically reduced atherosclerosis and significantly lowered BP in both NNee and nnee mice compared with animals treated with control pellets. Thus exogenous E2 has strong BP-lowering and atheroprotective effects in apoE-deficient mice, but eNOS is not essential for either effect. Endogenous sex hormones, on the other hand, cause significant damage to the vasculature in the absence of eNOS, but these effects are overridden by interactions between eNOS and sex hormones.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11854327      PMCID: PMC150875          DOI: 10.1172/JCI14066

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  39 in total

Review 1.  Estrogens and atherosclerosis.

Authors:  L Nathan; G Chaudhuri
Journal:  Annu Rev Pharmacol Toxicol       Date:  1997       Impact factor: 13.820

2.  Induction of calcium-dependent nitric oxide synthases by sex hormones.

Authors:  C P Weiner; I Lizasoain; S A Baylis; R G Knowles; I G Charles; S Moncada
Journal:  Proc Natl Acad Sci U S A       Date:  1994-05-24       Impact factor: 11.205

3.  Differing responses in blood pressure over 24 hours in normotensive women receiving oral or transdermal estrogen replacement therapy.

Authors:  A A Akkad; A W Halligan; K Abrams; F al-Azzawi
Journal:  Obstet Gynecol       Date:  1997-01       Impact factor: 7.661

4.  Significant reduction of the antiatherogenic effect of estrogen by long-term inhibition of nitric oxide synthesis in cholesterol-clamped rabbits.

Authors:  P Holm; N Korsgaard; M Shalmi; H L Andersen; P Hougaard; S O Skouby; S Stender
Journal:  J Clin Invest       Date:  1997-08-15       Impact factor: 14.808

Review 5.  Postmenopausal hormone replacement therapy and cardiovascular disease.

Authors:  C U Chae; P M Ridker; J E Manson
Journal:  Thromb Haemost       Date:  1997-07       Impact factor: 5.249

6.  Elevated blood pressures in mice lacking endothelial nitric oxide synthase.

Authors:  E G Shesely; N Maeda; H S Kim; K M Desai; J H Krege; V E Laubach; P A Sherman; W C Sessa; O Smithies
Journal:  Proc Natl Acad Sci U S A       Date:  1996-11-12       Impact factor: 11.205

7.  Angiotensin-converting enzyme gene and atherosclerosis.

Authors:  J H Krege; J S Moyer; L L Langenbach; L Peng; S H Zhang; N Maeda; R L Reddick; O Smithies
Journal:  Arterioscler Thromb Vasc Biol       Date:  1997-07       Impact factor: 8.311

8.  Hypertension in mice lacking the gene for endothelial nitric oxide synthase.

Authors:  P L Huang; Z Huang; H Mashimo; K D Bloch; M A Moskowitz; J A Bevan; M C Fishman
Journal:  Nature       Date:  1995-09-21       Impact factor: 49.962

9.  Estrogen reduces atherosclerotic lesion development in apolipoprotein E-deficient mice.

Authors:  P A Bourassa; P M Milos; B J Gaynor; J L Breslow; R J Aiello
Journal:  Proc Natl Acad Sci U S A       Date:  1996-09-17       Impact factor: 11.205

10.  Diet-induced atherosclerosis in mice heterozygous and homozygous for apolipoprotein E gene disruption.

Authors:  S H Zhang; R L Reddick; B Burkey; N Maeda
Journal:  J Clin Invest       Date:  1994-09       Impact factor: 14.808

View more
  18 in total

Review 1.  Sex as a Biological Variable in Atherosclerosis.

Authors:  Joshua J Man; Joshua A Beckman; Iris Z Jaffe
Journal:  Circ Res       Date:  2020-04-23       Impact factor: 17.367

2.  Dimethylarginine dimethylaminohydrolase overexpression ameliorates atherosclerosis in apolipoprotein E-deficient mice by lowering asymmetric dimethylarginine.

Authors:  Johannes Jacobi; Renke Maas; Arturo J Cardounel; Michaela Arend; Arthur J Pope; Nada Cordasic; Juliane Heusinger-Ribeiro; Dorothee Atzler; Joachim Strobel; Edzard Schwedhelm; Rainer H Böger; Karl F Hilgers
Journal:  Am J Pathol       Date:  2010-03-26       Impact factor: 4.307

3.  Comparison of diabetic nephropathy between male and female eNOS-/- db/db mice.

Authors:  Yuhong Ma; Weizu Li; Parisa Yazdizadeh Shotorbani; Brooke Hopkins Dubansky; Linjing Huang; Sarika Chaudhari; Peiwen Wu; Lei A Wang; Myoung-Gwi Ryou; Zhengyang Zhou; Rong Ma
Journal:  Am J Physiol Renal Physiol       Date:  2019-02-27

4.  Activation function 2 (AF2) of estrogen receptor-alpha is required for the atheroprotective action of estradiol but not to accelerate endothelial healing.

Authors:  Audrey Billon-Galés; Andrée Krust; Coralie Fontaine; Anne Abot; Gilles Flouriot; Céline Toutain; Hortense Berges; Alain-Pierre Gadeau; Françoise Lenfant; Pierre Gourdy; Pierre Chambon; Jean-François Arnal
Journal:  Proc Natl Acad Sci U S A       Date:  2011-07-25       Impact factor: 11.205

5.  Kinase-mediated regulation of common transcription factors accounts for the bone-protective effects of sex steroids.

Authors:  Stavroula Kousteni; Li Han; Jin-Ran Chen; Maria Almeida; Lilian I Plotkin; Teresita Bellido; Stavros C Manolagas
Journal:  J Clin Invest       Date:  2003-06       Impact factor: 14.808

6.  Estrogen protects against intracranial aneurysm rupture in ovariectomized mice.

Authors:  Yoshiteru Tada; Kosuke Wada; Kenji Shimada; Hiroshi Makino; Elena I Liang; Shoko Murakami; Mari Kudo; Fumiaki Shikata; Ricardo A Pena Silva; Keiko T Kitazato; David M Hasan; Yasuhisa Kanematsu; Shinji Nagahiro; Tomoki Hashimoto
Journal:  Hypertension       Date:  2014-04-14       Impact factor: 10.190

7.  Sex-Specific Effect of Endothelin in the Blood Pressure Response to Acute Angiotensin II in Growth-Restricted Rats.

Authors:  Suttira Intapad; Norma B Ojeda; Elliott Varney; Thomas P Royals; Barbara T Alexander
Journal:  Hypertension       Date:  2015-10-12       Impact factor: 10.190

8.  Inhibition of XO or NOX attenuates diethylstilbestrol-induced endothelial nitric oxide deficiency without affecting its effects on LNCaP cell invasion and apoptosis.

Authors:  Ji-Youn Youn; Andrew Nguyen; Hua Cai
Journal:  Clin Sci (Lond)       Date:  2012-10       Impact factor: 6.124

9.  Inhibition of renin-angiotensin system reverses endothelial dysfunction and oxidative stress in estrogen deficient rats.

Authors:  Lai Ming Yung; Wing Tak Wong; Xiao Yu Tian; Fung Ping Leung; Lai Hang Yung; Zhen Yu Chen; Xiaoqiang Yao; Chi Wai Lau; Yu Huang
Journal:  PLoS One       Date:  2011-03-29       Impact factor: 3.240

10.  Blood pressure, sex, and female sex hormones influence renal inner medullary nitric oxide synthase activity and expression in spontaneously hypertensive rats.

Authors:  Jennifer M Sasser; Krystal N Brinson; Ashlee J Tipton; G Ryan Crislip; Jennifer C Sullivan
Journal:  J Am Heart Assoc       Date:  2015-04-10       Impact factor: 5.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.